Hutch News

Hutch News

Stories tagged 'hiv aids'

The pride of Fred Hutch

HIV Vaccine Trials Network veteran Steven Wakefield named a grand marshal in Seattle Pride Parade

June 7, 2018 | By Mary Engel / Fred Hutch News Service

During Pride Month, a parade of honors is in store for HIV Vaccine Trials Network veteran Steven Wakefield, external relations director for the Fred Hutch–based global group.

View story >


25 powerful years of HIV research

Longstanding Mombasa Cohort helps answer questions about HIV risk and transmission

Feb. 26, 2018 | By Sabrina Richards / Fred Hutch News Service

For 25 years, Fred Hutch virologist Dr. Julie Overbaugh has helped lead the Mombasa Cohort, a unique group of women at high risk for HIV transmission.

View story >


Meet Peru's HIV superhero

By finding a better way to prevent HIV, Dr. Jorge Sanchez aims to help end his country’s AIDS epidemic

Jan. 22, 2018 | By Mary Engel / Fred Hutch News Service

A leader in Peru's battle against HIV/AIDS, Dr. Jorge Sanchez's superpower is research. He is working with the Fred Hutch-based HIV Vaccine Trials Network on a potentially landmark prevention study.

View story >


A voice for HIV cure

As researchers work toward a cure, advocate Tranisha Arzah keeps the focus on community

Nov. 29, 2017 | By Mary Engel / Fred Hutch News Service

Born with HIV, Tranisha Arzah joined the community advisory board for the Fred Hutch-based cure research group defeatHIV to "see if I could get other women involved and make sure they have a voice.”

View story >


Enlisting the microbiome in the quest for an AIDS vaccine

We now know that microbial communities, especially in our guts, profoundly affect immune response

Nov. 22, 2017 | By Sabin Russell / Fred Hutch News Service

Scientists at Fred Hutch are studying how the microbiome alters the immune system’s response to vaccines. Their work is already providing new insights on interactions between microbes in the body and the immune system that have implications for improving many types of vaccines.

View story >


For cancer patients with HIV, immunotherapy appears safe

Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials

Nov. 7, 2017 | By Mary Engel / Fred Hutch News Service

Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.